Abstract

Reporter proteins have become an indispensable tool in biomedical research. However, exogenous introduction of these reporters into mice poses a risk of rejection by the immune system. Here, we describe the generation, validation and application of a multiple reporter protein tolerant ‘Tol' mouse model that constitutively expresses an assembly of shuffled reporter proteins from a single open reading frame. We demonstrate that expression of the Tol transgene results in the deletion of CD8+ T cells specific for a model epitope, and substantially improves engraftment of reporter-gene transduced T cells. The Tol strain provides a valuable mouse model for cell transfer and viral-mediated gene transfer studies, and serves as a methodological example for the generation of poly-tolerant mouse strains.

Bresser and Dijkgraaf et al. develop the ‘Tol’ strain, a genetically modified mouse model that expresses a range of shuffled reporter and modifier proteins from a single open reading frame. This strain is immunologically tolerant to these reporter and modifier proteins, providing a valuable model system for cell transfer studies and virus-mediated gene transfer studies.

Details

Title
A mouse model that is immunologically tolerant to reporter and modifier proteins
Author
Bresser Kaspar 1   VIAFID ORCID Logo  ; Dijkgraaf Feline E 1 ; Pritchard Colin E J 2 ; Huijbers, Ivo J 2   VIAFID ORCID Logo  ; Ji-Ying, Song 3 ; Rohr, Jan C 4 ; Scheeren, Ferenc A 5   VIAFID ORCID Logo  ; Schumacher, Ton N 6   VIAFID ORCID Logo 

 The Netherlands Cancer Institute, Division of Molecular Oncology & Immunology, Oncode Institute, Amsterdam, The Netherlands (GRID:grid.430814.a) 
 The Netherlands Cancer Institute, Mouse Clinic for Cancer and Aging research (MCCA) Transgenic Facility, Amsterdam, The Netherlands (GRID:grid.430814.a) 
 The Netherlands Cancer Institute, Animal Pathology, Amsterdam, The Netherlands (GRID:grid.430814.a) 
 University of Freiburg, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) 
 Leiden University Medical Center, Department of Medical Oncology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
 The Netherlands Cancer Institute, Division of Molecular Oncology & Immunology, Oncode Institute, Amsterdam, The Netherlands (GRID:grid.430814.a); Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2407753776
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.